DK0592594T3 - Tabletter med højt indhold af colestipol-hydrochlorid - Google Patents

Tabletter med højt indhold af colestipol-hydrochlorid

Info

Publication number
DK0592594T3
DK0592594T3 DK92915578T DK92915578T DK0592594T3 DK 0592594 T3 DK0592594 T3 DK 0592594T3 DK 92915578 T DK92915578 T DK 92915578T DK 92915578 T DK92915578 T DK 92915578T DK 0592594 T3 DK0592594 T3 DK 0592594T3
Authority
DK
Denmark
Prior art keywords
tablet
tablets
colestipol hydrochloride
high content
scus
Prior art date
Application number
DK92915578T
Other languages
Danish (da)
English (en)
Inventor
Robert Wu-Wei Shen
Jeffrey Ellis Price
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK0592594T3 publication Critical patent/DK0592594T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DK92915578T 1991-07-03 1992-06-23 Tabletter med højt indhold af colestipol-hydrochlorid DK0592594T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72504491A 1991-07-03 1991-07-03
PCT/US1992/005066 WO1993000915A1 (en) 1991-07-03 1992-06-23 Colestipol hydrochloride high-content tablets

Publications (1)

Publication Number Publication Date
DK0592594T3 true DK0592594T3 (da) 1999-08-16

Family

ID=24912923

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92915578T DK0592594T3 (da) 1991-07-03 1992-06-23 Tabletter med højt indhold af colestipol-hydrochlorid

Country Status (18)

Country Link
US (1) US5490987A (cs)
EP (1) EP0592594B1 (cs)
JP (1) JP3313710B2 (cs)
KR (1) KR100240362B1 (cs)
AT (1) ATE173931T1 (cs)
AU (1) AU669664B2 (cs)
CA (1) CA2110166C (cs)
CZ (1) CZ286958B6 (cs)
DE (1) DE69227773T2 (cs)
DK (1) DK0592594T3 (cs)
ES (1) ES2124736T3 (cs)
FI (1) FI106843B (cs)
HU (1) HU222242B1 (cs)
NO (1) NO307686B1 (cs)
PL (1) PL169045B1 (cs)
RU (1) RU2108090C1 (cs)
SK (1) SK281920B6 (cs)
WO (1) WO1993000915A1 (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2129079C (en) * 1993-08-03 2006-01-17 Tatsuo Nomura Orally administrable cholesterol lowering agent
NZ503086A (en) * 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
ATE286386T1 (de) * 1999-10-19 2005-01-15 Genzyme Corp Direktkomprimierter tablettenkern auf polymerbasis
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
GB0123400D0 (en) 2001-09-28 2001-11-21 Novartis Ag Organic compounds
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
AU2004311849B2 (en) * 2003-12-31 2009-04-02 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
CA2620406A1 (en) 2005-09-02 2007-03-08 Genzyme Corporation Method for removing phosphate and polymer used therefore
PT1924246E (pt) 2005-09-15 2016-02-10 Genzyme Corp Formulação sachê para polímeros com funcionalidade amina
BRPI0717008A2 (pt) * 2006-09-01 2014-01-21 Usv Ltd Processo para o preparo de cloridrato de sevelamer e formulação do mesmo
US7964182B2 (en) * 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
BRPI0717545A2 (pt) 2006-09-29 2013-10-22 Gezyme Corp Composição farmacêutica, método para tratar uma doença, polímero de amida, rede de polímero, e, método para preparar um polímero de amida
EP2120972A1 (en) 2006-12-14 2009-11-25 Genzyme Corporation Amido-amine polymer compositions
CA2735962A1 (en) * 2008-09-02 2010-04-15 Usv Limited Crosslinked polymers
AU2010209293A1 (en) * 2009-01-22 2011-09-08 Usv Limited Pharmaceutical compositions comprising phosphate-binding polymer
US9763928B2 (en) * 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
MA41202A (fr) 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803237A (en) * 1969-11-03 1974-04-09 Upjohn Co Reaction products of polyethylenepolyamines and chlorohydrins or epoxy containing compounds
US3692895A (en) * 1970-09-08 1972-09-19 Norman A Nelson Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria
ZA804914B (en) * 1979-08-29 1981-08-26 Rohm & Haas The production of powdered resin and the powdered resin so produced
US4439419A (en) * 1980-02-20 1984-03-27 The Upjohn Company Method of treating gastric hyperacidity in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance as epichlorhydrin
US4404346A (en) * 1980-08-05 1983-09-13 Rohm And Haas Company Production of powdered resin and the powdered resin so produced
US4631305A (en) * 1985-03-22 1986-12-23 The Upjohn Company Polymeric material as a disintegrant in a compressed tablet
CS255081B1 (cs) * 1985-12-21 1988-02-15 Arnost Pospisil Způsob Výroby tablet s časové řízenou liberací obsahující nestálou a/nabo dráidivou fyziologicky aktivní složku
ATE91627T1 (de) * 1988-06-24 1993-08-15 Upjohn Co Feingemahlenes colestipol-hydrochlorid.
IE63242B1 (en) * 1988-06-24 1995-04-05 Abbott Lab Pharmaceutical granules and tablets made therefrom
DE68911146T2 (de) * 1988-08-26 1994-04-14 Upjohn Co Feinkörniges colestipol hydrochlorid.

Also Published As

Publication number Publication date
FI935943L (fi) 1993-12-30
HUT69394A (en) 1995-09-28
WO1993000915A1 (en) 1993-01-21
FI935943A0 (fi) 1993-12-30
US5490987A (en) 1996-02-13
JPH06509097A (ja) 1994-10-13
DE69227773D1 (de) 1999-01-14
JP3313710B2 (ja) 2002-08-12
EP0592594B1 (en) 1998-12-02
RU2108090C1 (ru) 1998-04-10
EP0592594A1 (en) 1994-04-20
PL169045B1 (pl) 1996-05-31
NO940008D0 (no) 1994-01-03
FI106843B (fi) 2001-04-30
SK281920B6 (sk) 2001-09-11
CA2110166C (en) 2002-11-05
DE69227773T2 (de) 1999-05-20
CA2110166A1 (en) 1993-01-21
HU222242B1 (hu) 2003-05-28
HU9400004D0 (en) 1994-05-30
NO307686B1 (no) 2000-05-15
CZ282693A3 (en) 1994-06-15
KR100240362B1 (ko) 2000-02-01
ATE173931T1 (de) 1998-12-15
AU2293392A (en) 1993-02-11
AU669664B2 (en) 1996-06-20
ES2124736T3 (es) 1999-02-16
CZ286958B6 (cs) 2000-08-16
SK194A3 (en) 1994-11-09
NO940008L (no) 1994-01-03

Similar Documents

Publication Publication Date Title
DK0592594T3 (da) Tabletter med højt indhold af colestipol-hydrochlorid
Jick Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients
EP1258245A3 (en) Accelerated release composition containing bromocriptine
AU2725392A (en) Hiv protease inhibitors
MY109834A (en) Benzoxazinones as inhibitors of hiv reverse transcriptase
AU2553992A (en) Bone-growth-stimulating composition
KR930007441A (ko) 의약품
DK0558468T3 (da) Lægemiddel til inhibering af nitrogenoxiddannelse
BR9709838A (pt) Regime de administração que fornece um perfil de plasma no sangue de um inibidor de h+,k+-atpase composição farmacêutica oral uso da mesma e de inibidor h+,k+-atpase e processos para melhorar a inibição de secreção de ácido gástrico e o efeito terapêutico no tratamento de perturbações gastrintestinais e para receber um perfil estendido de plasma de um inibidor de h+,k+-atpase
ATE258788T1 (de) Tablette
NO962752L (no) Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose
CO5570661A2 (es) Combinaciones que comprenden inhibidores de cox-2 y aspirina
MY114716A (en) Prophylactic and/or therapeutic treatment of dyspeptic symptoms
Morrow et al. A comparison of diclofenac and ketorolac for postoperative analgesia following day‐case arthroscopy of the knee joint
EP0302714A3 (en) Pharmaceutical composition for treatment of bone-wasting diseases
Lim et al. The antiemetic and sysphoric effects of droperidol in the day surgery patient
Chapman Postoperative pain control for outpatient oral surgery
ES2087915T3 (es) Agente terapeutico y procedimiento que inhibe la vascularizacion de tumores.
BG101803A (en) Use of melatonin for treating patients suffering from drug addiction
PT891186E (pt) Administração nasal de agentes para o tratamento de emese tardia
ES2042831T3 (es) Procedimiento de preparacion de una composicion farmaceutica para el tratamiento de la osteoporosis.
Boyd et al. Review of ulcer treatment: role of ranitidine
MXPA02006146A (es) Uso de metabolitos bioactivos de gepirona para el tratamiento de desordenes psicologicos.
Gumpel Cyclophosphamide, gold and penicillamine—disease-modifying drugs in rheumatoid arthritis—tailored dosage and ultimate success
Taylor et al. Laparoscopic vagotomy: an operation for the 1990s?